EU’s Pharma Package falls short of Europe’s goal of global competitiveness
In a bid to chase competitiveness, the EU is advancing its most drastic revision of pharmaceutical law in 20 years. …
Post
-
-
AbbVie buys $2.1bn Capstan, adding new in vivo CAR-T to pipeline
AbbVie has agreed to acquire Capstan Therapeutics for up to $2.1bn, adding a “high-risk, high-reward” clinical-stage in vivo CAR-T candidate …
-
Piramal Pharma announces $90m investment to expand US sites
Piramal Pharma Solutions has announced an investment of $90m to expand its two US facilities, enhancing manufacturing capabilities for sterile …
-
FDA approves Takeda’s Gammagard liquid ERC for primary immunodeficiency
The US Food and Drug Administration (FDA) has approved Takeda’s new immunoglobulin (IG) therapy, Gammagard liquid ERC [immune globulin infusion …
-
WHO accuses China of withholding Covid-19 genetic data
The World Health Organization (WHO) says it is unable to concretely identify the origins of the virus that led to …
-
WHO accuses China of withholding Covid-19 genetic data
The World Health Organization (WHO) says it is unable to concretely identify the origins of the virus that led to …
-
US trade tariffs and the potential impact on pharma supply chains
When Donald Trump was elected the 47th president of the United States of America, the outlook for pharmaceuticals was unclear, …
-
Vetter breaks ground on $285m US clinical manufacturing site
German contract development and manufacturing organisation Vetter Pharma has commenced construction of a new $285m clinical manufacturing facility in Des …
-
CKD anemia market expected to reach $5.3bn across the 7MM by 2034
The chronic kidney disease (CKD) anemia market across the seven major markets (7MM: the US, France, Germany, Italy, Spain, the …
-
FDA removes safety programme for CAR-T therapies to boost uptake
The US Food and Drug Administration (FDA) has removed the risk evaluation and mitigation strategies (REMS) requirements for all approved …
-
Sobi gains FDA approval for Gamifant to treat HLH/MAS
The US Food and Drug Administration (FDA) has approved Sobi's Gamifant (emapalumab) to treat adults and children with haemophagocytic lymphohistiocytosis …
-
Torrent Pharmaceuticals to acquire stake in JB Pharma for $3bn
Torrent Pharmaceuticals, headquartered in Gujerat, India, has signed definitive agreements for the acquisition of a controlling stake in JB Chemicals …
-
FDA approves label updates for BMS’ CAR T cell therapies
Bristol Myers Squibb (BMS) has announced that the US Food and Drug Administration (FDA) has given approval to label updates …
-
AI in drug discovery: from hypothetical to reality
AI has been a buzzword in the pharmaceutical industry for almost a decade, with countless headlines promising to revolutionise how …
-
Viatris gains China approval for Yupelri to treat COPD
Theravance Biopharma’s partner Viatris has received China's National Medical Products Administration (NMPA) approval for Yupelri (revefenacin) inhalation solution for maintenance …
